Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

biopharmadive.com

BioPharma Dive - Latest News

Get the latest updates from BioPharma Dive - Latest News directly as they happen.

Follow now 126 followers

Latest posts

Last updated about 4 hours ago

Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval

about 4 hours ago

Hong Kong-based CSPC will receive $120 million from Madrigal under the deal...

Vinay Prasad’s ouster leaves biotech guessing at FDA direction

about 4 hours ago

The abrupt exit of the former CBER director, who quickly made his...

J&J tests direct CAR-T marketing with first Carvykti ad

about 5 hours ago

The new direct-to-consumer ad signals J&J’s confidence in its capacity to meet...

Vinay Prasad, controversial FDA official, abruptly departs agency

about 17 hours ago

Prasad's exit ends a tumultuous tenure during which he led a reworking...

Merck plans spending shift to boost business beyond Keytruda

1 day ago

Facing an end to Keytruda's market exclusivity, the company will cut $3...

Novo cuts guidance, names new CEO as obesity drug challenges mount

1 day ago

Knockoff copies of Novo’s weight loss medicine Wegovy have held back sales...

Bavarian Nordic agrees to $3B take-private deal

1 day ago

The vaccine maker’s board intends to recommend a pending offer from investment...

Bain leads $300M investment in startup built on Bristol Myers immune drugs

1 day ago

Bristol Myers will get a nearly 20% stake in the startup, which...

Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival

1 day ago

Led by former Novartis executive Emanuele Ostuni, the startup has a prostate...

FDA allows Sarepta to resume some Elevidys shipments

2 days ago

The company can again ship the Duchenne gene therapy for patients who...

Adaptimmune, seeking to stay afloat, sells off cell therapies

2 days ago

A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and...

Celcuity shares triple on late-stage results for breast cancer therapy

2 days ago

Trial data showed the drug dramatically reduced cancer progression risk in certain...